NCT04551040View on ClinicalTrials.gov

Target Engagement of Terazosin in Healthy Adults

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 26, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

June 30, 2025

Conditions
Healthy
Interventions
DRUG

Terazosin

Terazosin 1 mg oral capsule

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

University of Iowa

OTHER